MedPath

NALOXONE HYDROCHLORIDE

NALOXONE HYDROCHLORIDE INJECTION, USP 0.4mg/mL 1mL CARP

Approved
Approval ID

74fcd243-94b3-ec77-e053-2991aa0a229c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 9, 2022

Manufacturers
FDA

HF Acquisition Co. LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NALOXONE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code51662-1238
Application NumberANDA070172
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateDecember 9, 2022
Generic NameNALOXONE HYDROCHLORIDE

INGREDIENTS (4)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
NALOXONE HYDROCHLORIDEActive
Quantity: 0.4 mg in 1 mL
Code: F850569PQR
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NALOXONE HYDROCHLORIDE - FDA Drug Approval Details